As the world learned in the early months of the COVID-19 pandemic, emergencies can quickly swamp global supply chains and threaten patient access to needed medications. Whether resulting from natural disasters or geopolitical tensions driving increased demand for medications or disruptions to manufacturing and transportation, supply chain vulnerabilities put populations at risk.
This report examines strategies to avoid drug shortages and how Cortellis Product Intelligence™ can help manufacturers identify the best partners and plan for the unexpected. Topics addressed include:
- Challenges pharmas face in trying to establish a sound supply chain
- Key vulnerabilities including regulatory considerations as well as geopolitical factors
- Strategies supply chain teams can adopt to guard against disruption
- How Cortellis Product Intelligence can help companies future-proof their supply chains
